{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Cancer Immunotherapy Paves the Way for Better Understanding of COVID-19

Activity Steps


Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Purpose of Activity

To provide an overview of how knowledge learned in cancer immunotherapy may help practitioners individualize treatments based on the different immune responses of their patients with COVID-19.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Evaluate how cancer research has contributed to our current understanding of COVID-19.
  2. Assess how the COVID-19 pandemic has affected the current state of scientific research.
  3. Summarize what we have learned about the role of immunology in our treatment of patients with COVID-19.
Price: $10.00


  • ACCME 1.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Professions: Physician
Test Code: OT0820
Published: August 2020
Expires: 7/31/2022
Sources: Oncology Times
Required Passing Score: 7/10 (70%)
Authors: Peggy Eastman
Categories: Hematology , Oncology
Specialties: Hematology, Oncology